Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in ZLD?
Zelda Therapeutics Ltd: THE INVESTMENT CASE

Zelda's Stewart Washer discussed medical cannabis trials with investors at Proactive's CEO Sessions

Stewart Washer at Proactive's CEO Sessions this week.
Zelda's Stewart Washer at Proactive's CEO Sessions
INVESTMENT OVERVIEW: ZLD The Big Picture
Stewart Washer, executive director, presenting at Proactive's CEO Sessions

Zelda Therapeutics Ltd's (ASX:ZLD) executive director, Stewart Washer, joined Proactive's CEO Sessions in Melbourne and Sydney this week.

Zelda is developing a range of cannabinoid-based formulations to treat medical conditions.

WATCH NOW: Zelda Therapeutics' Dr Stewart Washer presents at Proactive's CEO Sessions

ACCESS THE FULL PRESENTATION HERE

View full ZLD profile View Profile

Zelda Therapeutics Ltd Timeline

Related Articles

hepatitisC.jpg
January 19 2018
Regulatory sign-off fires starting pistol on the commercial launch in Europe, Africa, EU Medical Devices Directive awarded CE IVD certification, molecular diagnostics, Europe, Africa, Sysmex
leg bones
March 31 2018
"We are now in the position of really trying to kick on in 2018"
blood
April 01 2018
The company is in the process of raising £5mln, with a possible further £1mln through a share issue at 52.5p

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use